Spike glycoprotein / ACE2_HUMAN hetero-oligomeric complex | P0DTC2, Q9BYF1

Created: May 5, 2023, 9:34 p.m. at 21:34

Models Name Description GMQE QSQE Seq Id Coverage Range Method Resolution Oligo-state Ligands Found by Seq Similarity
7dwx.1
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.77 0.58 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-6-2-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.62
7dwx.1
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.77 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-6-2-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.62
7dx5.1
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
 0.72 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-1-mer 29 x NAG, 26 x NAG-NAG HHblits 0.62
7dx5.1
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
 0.71 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-1-mer 29 x NAG, 26 x NAG-NAG HHblits 0.62
7dx6.1
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
 0.72 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx6.1
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
 0.71 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx7.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.70 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx7.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.72 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx8.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
 0.72 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7dx8.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
 0.71 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7dx8.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
 0.72 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7dx9.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
 0.72 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7dx9.1
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
 0.72 99.90 1.00 2-805
1-1273		 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7xo7.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.70 98.12 1.00 1-805
1-1273		 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN HHblits 0.61
7xo7.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.70 98.12 1.00 1-805
1-1273		 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN HHblits 0.61
7xo8.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
 0.71 98.12 1.00 1-805
1-1273		 EM 0.00 hetero-3-3-mer 39 x NAG, 3 x ZN HHblits 0.61
7xo9.1
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2
 0.31 98.12 1.00 1-805
1-1273		 EM 0.00 hetero-1-1-mer 1 x ZN, 3 x NAG HHblits 0.61
7xo7.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.70 98.21 0.99 1-805
12-1273		 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN BLAST / HHblits 0.61
7xo7.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.70 98.21 0.99 1-805
12-1273		 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN BLAST / HHblits 0.61
7xo8.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
 0.71 98.21 0.99 1-805
12-1273		 EM 0.00 hetero-3-3-mer 39 x NAG, 3 x ZN BLAST / HHblits 0.61
7xoa.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
 0.69 91.18 1.00 1-805
1-1273		 EM 0.00 hetero-3-1-mer 34 x NAG, 1 x ZN HHblits 0.59
7xob.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
 0.70 91.18 1.00 1-805
1-1273		 EM 0.00 hetero-3-2-mer 37 x NAG, 2 x ZN HHblits 0.59
7xob.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
 0.70 91.18 1.00 1-805
1-1273		 EM 0.00 hetero-3-2-mer 37 x NAG, 2 x ZN HHblits 0.59
7xoc.1
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with mouse ACE2
 0.30 91.18 1.00 1-805
1-1273		 EM 0.00 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG HHblits 0.59
7xoa.1
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
 0.70 91.23 0.99 1-805
12-1273		 EM 0.00 hetero-3-1-mer 34 x NAG, 1 x ZN BLAST / HHblits 0.59
7wpa.1
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
 0.60 97.71 0.97 1-805
1-1208		 EM 0.00 hetero-3-1-mer 21 x NAG, 1 x ZN, 12 x NAG-NAG HHblits 0.61
7wpa.1
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
 0.60 97.71 0.97 1-805
1-1208		 EM 0.00 hetero-3-1-mer 21 x NAG, 1 x ZN, 12 x NAG-NAG HHblits 0.61
7wpb.1
SARS-CoV-2 Omicron Variant RBD complexed with ACE2
 0.31 97.71 0.97 1-805
1-1208		 EM 0.00 hetero-1-1-mer 3 x NAG, 1 x ZN HHblits 0.61
7wpc.1
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
 0.30 97.71 0.97 1-805
1-1208		 EM 0.00 hetero-2-1-mer 1 x ZN, 3 x NAG, 2 x NAG-NAG HHblits 0.61
7wpc.1
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
 0.30 97.71 0.97 1-805
1-1208		 EM 0.00 hetero-2-1-mer 1 x ZN, 3 x NAG, 2 x NAG-NAG HHblits 0.61
7xid.1
S-ECD (Omicron) in complex with PD of ACE2
 0.68 97.51 0.97 2-805
1-1208		 EM 0.00 hetero-3-2-mer 37 x NAG, 23 x NAG-NAG HHblits 0.61
7xid.1
S-ECD (Omicron) in complex with PD of ACE2
 0.68 97.51 0.97 2-805
1-1208		 EM 0.00 hetero-3-2-mer 37 x NAG, 23 x NAG-NAG HHblits 0.61
7wpa.1
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
 0.60 98.25 0.96 1-805
12-1208		 EM 0.00 hetero-3-1-mer 21 x NAG, 1 x ZN, 12 x NAG-NAG BLAST / HHblits 0.61
7wpa.1
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
 0.60 98.25 0.96 1-805
12-1208		 EM 0.00 hetero-3-1-mer 21 x NAG, 1 x ZN, 12 x NAG-NAG BLAST / HHblits 0.61
7wpb.1
SARS-CoV-2 Omicron Variant RBD complexed with ACE2
 0.31 98.25 0.96 1-805
12-1208		 EM 0.00 hetero-1-1-mer 3 x NAG, 1 x ZN BLAST / HHblits 0.61
7wpc.1
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
 0.30 98.25 0.96 1-805
12-1208		 EM 0.00 hetero-2-1-mer 1 x ZN, 3 x NAG, 2 x NAG-NAG BLAST / HHblits 0.61
7wpc.1
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
 0.30 98.25 0.96 1-805
12-1208		 EM 0.00 hetero-2-1-mer 1 x ZN, 3 x NAG, 2 x NAG-NAG BLAST / HHblits 0.61
7xid.1
S-ECD (Omicron) in complex with PD of ACE2
 0.68 98.05 0.96 2-805
12-1208		 EM 0.00 hetero-3-2-mer 37 x NAG, 23 x NAG-NAG BLAST / HHblits 0.61
7xid.1
S-ECD (Omicron) in complex with PD of ACE2
 0.69 98.05 0.96 2-805
12-1208		 EM 0.00 hetero-3-2-mer 37 x NAG, 23 x NAG-NAG BLAST / HHblits 0.61
8dv2.1
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
 0.32 99.59 0.93 18-740
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG BLAST / HHblits 0.62
8dv1.1
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
 0.32 99.53 0.93 18-740
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG BLAST / HHblits 0.62
7xo4.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
 0.65 0.42 90.53 0.97 1-805
1-1208		 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN HHblits 0.59
7xo4.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
 0.65 0.42 90.53 0.97 1-805
1-1208		 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN HHblits 0.59
7xo5.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
 0.60 90.53 0.97 1-805
1-1208		 EM 0.00 hetero-3-1-mer 37 x NAG, 1 x ZN HHblits 0.59
7xo5.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
 0.61 90.53 0.97 1-805
1-1208		 EM 0.00 hetero-3-1-mer 37 x NAG, 1 x ZN HHblits 0.59
7xo6.1
SARS-CoV-2 Omicron BA.1 Variant RBD with mouse ACE2 Bound
 0.30 90.53 0.97 1-805
1-1208		 EM 0.00 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG HHblits 0.59
7xo4.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
 0.65 91.03 0.96 1-805
12-1208		 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN BLAST / HHblits 0.59
7xo4.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
 0.65 91.03 0.96 1-805
12-1208		 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN BLAST / HHblits 0.59
7xo5.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
 0.60 91.03 0.96 1-805
12-1208		 EM 0.00 hetero-3-1-mer 37 x NAG, 1 x ZN BLAST / HHblits 0.59
7xo5.1
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
 0.61 91.03 0.96 1-805
12-1208		 EM 0.00 hetero-3-1-mer 37 x NAG, 1 x ZN BLAST / HHblits 0.59
7xo6.1
SARS-CoV-2 Omicron BA.1 Variant RBD with mouse ACE2 Bound
 0.29 91.03 0.96 1-805
12-1208		 EM 0.00 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG BLAST / HHblits 0.59
7ct5.1
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 99.89 0.90 19-615
1-1273		 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST / HHblits 0.62
7ct5.1
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 99.89 0.90 19-615
1-1273		 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST / HHblits 0.62
7ct5.1
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 99.89 0.90 19-615
1-1273		 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST / HHblits 0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
 0.58 99.37 0.92 18-740
15-1208		 EM 0.00 hetero-3-1-mer 27 x NAG, 16 x NAG-NAG BLAST 0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
 0.58 99.37 0.92 18-740
15-1208		 EM 0.00 hetero-3-1-mer 27 x NAG, 16 x NAG-NAG BLAST 0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
 0.59 99.37 0.92 18-740
15-1208		 EM 0.00 hetero-3-1-mer 27 x NAG, 16 x NAG-NAG BLAST 0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
 0.58 99.01 0.92 18-740
15-1208		 EM 0.00 hetero-3-1-mer 27 x NAG, 16 x NAG-NAG BLAST / HHblits 0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
 0.58 99.01 0.92 18-740
15-1208		 EM 0.00 hetero-3-1-mer 27 x NAG, 16 x NAG-NAG BLAST / HHblits 0.62
7fem.1
SARS-CoV-2 B.1.1.7 S-ACE2 complex
 0.59 99.01 0.92 18-740
15-1208		 EM 0.00 hetero-3-1-mer 27 x NAG, 16 x NAG-NAG BLAST / HHblits 0.62
7wgb.1
Neutral Omicron Spike Trimer in complex with ACE2
 0.65 97.74 0.90 19-612
1-1273		 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST / HHblits 0.61
7yr2.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.67 97.48 0.90 19-615
1-1273		 EM 3.30 hetero-3-1-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG BLAST / HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.68 97.48 0.90 19-615
1-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST / HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.69 97.48 0.90 19-615
1-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST / HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.69 97.48 0.90 19-615
1-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST / HHblits 0.61
7wgb.1
Neutral Omicron Spike Trimer in complex with ACE2
 0.65 97.74 0.90 20-612
1-1273		 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7yr2.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.67 97.48 0.90 20-615
1-1273		 EM 3.30 hetero-3-1-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.68 97.48 0.90 20-615
1-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.69 97.48 0.90 20-615
1-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.69 97.48 0.90 20-615
1-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG HHblits 0.61
7wgc.1
Neutral Omicron Spike Trimer in complex with ACE2.
 0.29 97.58 0.90 19-612
1-1273		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.61
7wgc.1
Neutral Omicron Spike Trimer in complex with ACE2.
 0.29 97.58 0.90 20-612
1-1273		 EM 0.00 hetero-1-1-mer 5 x NAG HHblits 0.61
7wgb.1
Neutral Omicron Spike Trimer in complex with ACE2
 0.65 98.27 0.89 19-612
12-1273		 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.62
7wgb.1
Neutral Omicron Spike Trimer in complex with ACE2
 0.65 98.27 0.89 20-612
12-1273		 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST / HHblits 0.62
7yr2.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.66 97.74 0.89 19-615
12-1273		 EM 3.30 hetero-3-1-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG BLAST 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.68 97.74 0.89 19-615
12-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.68 97.74 0.89 19-615
12-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.68 97.74 0.89 19-615
12-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST 0.61
7yr2.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.66 97.74 0.89 20-615
12-1273		 EM 3.30 hetero-3-1-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG BLAST / HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.68 97.74 0.89 20-615
12-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST / HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.68 97.74 0.89 20-615
12-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST / HHblits 0.61
7yr3.1
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.68 97.74 0.89 20-615
12-1273		 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST / HHblits 0.61
7wgc.1
Neutral Omicron Spike Trimer in complex with ACE2.
 0.28 98.11 0.89 19-612
12-1273		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST 0.61
7wgc.1
Neutral Omicron Spike Trimer in complex with ACE2.
 0.28 98.11 0.89 20-612
12-1273		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.61
7v85.1
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.69 99.34 0.88 1-615
1-1207		 EM 0.00 hetero-3-2-mer 13 x NAG, 31 x NAG-NAG HHblits 0.62
7v86.1
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
 0.71 99.34 0.88 1-615
1-1207		 EM 0.00 hetero-3-3-mer 13 x NAG, 37 x NAG-NAG HHblits 0.62
7v87.1
Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.30 99.34 0.88 1-615
1-1207		 EM 0.00 hetero-1-1-mer 4 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG HHblits 0.62
7v81.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.70 99.12 0.88 1-615
1-1207		 EM 0.00 hetero-3-2-mer 19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7v81.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.70 99.12 0.88 1-615
1-1207		 EM 0.00 hetero-3-2-mer 19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7v82.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
 0.70 99.12 0.88 1-615
1-1207		 EM 0.00 hetero-3-3-mer 26 x NAG, 29 x NAG-NAG HHblits 0.62
7v83.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
 0.70 99.12 0.88 1-615
1-1207		 EM 0.00 hetero-3-3-mer 29 x NAG, 30 x NAG-NAG HHblits 0.62
7v84.1
Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.31 99.12 0.88 1-615
1-1207		 EM 0.00 hetero-1-1-mer 3 x NAG, 5 x NAG-NAG HHblits 0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.69 99.23 0.88 1-615
1-1207		 EM 0.00 hetero-3-2-mer 15 x NAG, 37 x NAG-NAG HHblits 0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.69 99.23 0.88 1-615
1-1207		 EM 0.00 hetero-3-2-mer 15 x NAG, 37 x NAG-NAG HHblits 0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.68 99.23 0.88 1-615
1-1207		 EM 0.00 hetero-3-2-mer 15 x NAG, 37 x NAG-NAG HHblits 0.62
7v89.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
 0.70 99.23 0.88 1-615
1-1207		 EM 0.00 hetero-3-3-mer 14 x NAG, 43 x NAG-NAG HHblits 0.62
7v8a.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
 0.69 99.23 0.88 1-615
1-1207		 EM 0.00 hetero-3-3-mer 16 x NAG, 38 x NAG-NAG HHblits 0.62
7v8b.1
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.31 99.23 0.88 1-615
1-1207		 EM 0.00 hetero-1-1-mer 3 x NAG, 1 x NAG-NAG-BMA, 4 x NAG-NAG HHblits 0.62
7a94.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.69 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a94.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.69 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a94.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.69 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a95.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.64 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.62
7a95.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.64 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.62
7a95.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.64 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.62
7a96.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.64 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.62
7a96.1
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.63 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.62
7a97.1
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.65 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer HHblits 0.62
7a97.1
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.65 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer HHblits 0.62
7a97.1
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.64 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer HHblits 0.62
7a98.1
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
 0.63 99.89 0.87 19-615
1-1208		 EM 0.00 hetero-3-3-mer HHblits 0.62
7df4.1
SARS-CoV-2 S-ACE2 complex
 0.68 99.72 0.87 17-615
1-1208		 EM 0.00 hetero-3-1-mer 36 x NAG, 18 x NAG-NAG HHblits 0.62
7df4.1
SARS-CoV-2 S-ACE2 complex
 0.68 99.72 0.87 17-615
1-1208		 EM 0.00 hetero-3-1-mer 36 x NAG, 18 x NAG-NAG HHblits 0.62
7kms.1
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.68 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG BLAST / HHblits 0.62
7kms.1
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.68 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG BLAST / HHblits 0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.65 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG BLAST / HHblits 0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.65 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG BLAST / HHblits 0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.66 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG BLAST / HHblits 0.62
7knb.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.64 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG BLAST / HHblits 0.62
7knb.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.62 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG BLAST / HHblits 0.62
7kne.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.63 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG BLAST / HHblits 0.62
7kne.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.64 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG BLAST / HHblits 0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG BLAST / HHblits 0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG BLAST / HHblits 0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.64 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG BLAST / HHblits 0.62
7kni.1
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.66 99.72 0.87 19-615
1-1208		 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG BLAST / HHblits 0.62
7v7z.1
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
 0.68 98.96 0.88 1-615
1-1207		 EM 0.00 hetero-3-3-mer 17 x NAG, 31 x NAG-NAG HHblits 0.62
7v80.1
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.29 98.96 0.88 1-615
1-1207		 EM 0.00 hetero-1-1-mer 5 x NAG, 3 x NAG-NAG HHblits 0.62
7kms.1
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.68 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG HHblits 0.62
7kms.1
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.68 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG HHblits 0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.65 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG HHblits 0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.65 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG HHblits 0.62
7kmz.1
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.66 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG HHblits 0.62
7knb.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.63 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG HHblits 0.62
7knb.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.62 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG HHblits 0.62
7kne.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.63 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG HHblits 0.62
7kne.1
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.63 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG HHblits 0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.62
7knh.1
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.64 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.62
7kni.1
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.67 99.72 0.87 20-614
1-1208		 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG HHblits 0.62
7yeg.1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2
 0.63 99.50 0.87 19-615
1-1208		 EM 0.00 hetero-3-3-mer 36 x NAG, 3 x ZN, 6 x NAG-NAG BLAST / HHblits 0.62
✓
 7mjm.1
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain
 0.74 99.45 0.87 18-615
1-1208		 EM 0.00 hetero-3-2-mer 32 x NAG, 18 x NAG-NAG BLAST / HHblits 0.62
7vx5.1
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex
 0.31 99.39 0.87 17-615
1-1208		 EM 0.00 hetero-1-1-mer 1 x ZN, 5 x NAG HHblits 0.62
7vxa.1
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
 0.70 99.39 0.87 17-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxa.1
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
 0.70 99.39 0.87 17-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxb.1
SARS-CoV-2 Kappa variant spike protein in C2b state
 0.70 99.39 0.87 17-615
1-1208		 EM 3.90 hetero-3-1-mer HHblits 0.62
7vxb.1
SARS-CoV-2 Kappa variant spike protein in C2b state
 0.71 99.39 0.87 17-615
1-1208		 EM 3.90 hetero-3-1-mer HHblits 0.62
7vxc.1
SARS-CoV-2 Kappa variant spike protein in C3 state
 0.70 99.39 0.87 17-615
1-1208		 EM 3.90 hetero-3-1-mer HHblits 0.62
7sxx.1
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.64 99.45 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
7sxx.1
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.74 99.45 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
7sxy.1
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
 0.33 99.45 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7mjn.1
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
 0.32 99.45 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 5 x NAG HHblits 0.62
7sxz.1
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.65 99.39 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG HHblits 0.62
7sxz.1
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.74 99.39 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG HHblits 0.62
7sy0.1
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
 0.33 99.39 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7yeg.1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2
 0.63 99.50 0.87 20-614
1-1208		 EM 0.00 hetero-3-3-mer 36 x NAG, 3 x ZN, 6 x NAG-NAG HHblits 0.62
7sy1.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.65 99.39 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG HHblits 0.62
7sy1.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.74 99.39 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG HHblits 0.62
7sy2.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
 0.33 99.39 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7v85.1
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.69 99.34 0.87 1-615
12-1208		 EM 0.00 hetero-3-2-mer 13 x NAG, 31 x NAG-NAG BLAST / HHblits 0.62
7v86.1
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
 0.71 99.34 0.87 1-615
12-1208		 EM 0.00 hetero-3-3-mer 13 x NAG, 37 x NAG-NAG BLAST / HHblits 0.62
7sy7.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.65 99.28 0.87 18-615
1-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG BLAST / HHblits 0.62
7sy7.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.74 99.28 0.87 18-615
1-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG BLAST / HHblits 0.62
7sy3.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.65 99.34 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
7sy3.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.74 99.34 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
7sy3.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.65 99.34 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
7sy4.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
 0.32 99.34 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7sy5.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
 0.74 99.28 0.87 19-615
1-1208		 EM 0.00 hetero-3-3-mer 42 x NAG, 18 x NAG-NAG HHblits 0.62
7sy6.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
 0.33 99.28 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7sy8.1
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
 0.32 99.28 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7w98.1
SARS-CoV-2 Delta S-ACE2-C1
 0.70 99.33 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7w99.1
SARS-CoV-2 Delta S-ACE2-C2a
 0.70 99.33 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7w9b.1
SARS-CoV-2 Delta S-ACE2-C2b
 0.71 99.33 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7w9c.1
SARS-CoV-2 Delta S-ACE2-C3
 0.71 99.33 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7r12.1
Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
 0.34 99.44 0.87 19-613
1-1208		 EM 0.00 hetero-1-1-mer 1 x ZN, 6 x NAG HHblits 0.62
7tez.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.33 99.17 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7tf0.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
 0.65 99.17 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
7tf0.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
 0.75 99.17 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
7v81.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.70 99.12 0.87 1-615
12-1208		 EM 0.00 hetero-3-2-mer 19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMA BLAST / HHblits 0.62
7v81.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.70 99.12 0.87 1-615
12-1208		 EM 0.00 hetero-3-2-mer 19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMA BLAST / HHblits 0.62
7v82.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
 0.70 99.12 0.87 1-615
12-1208		 EM 0.00 hetero-3-3-mer 26 x NAG, 29 x NAG-NAG BLAST / HHblits 0.62
7v83.1
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
 0.70 99.12 0.87 1-615
12-1208		 EM 0.00 hetero-3-3-mer 29 x NAG, 30 x NAG-NAG BLAST / HHblits 0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.70 99.28 0.87 1-615
12-1208		 EM 0.00 hetero-3-2-mer 15 x NAG, 37 x NAG-NAG BLAST / HHblits 0.62
7v88.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
 0.69 99.28 0.87 1-615
12-1208		 EM 0.00 hetero-3-2-mer 15 x NAG, 37 x NAG-NAG BLAST / HHblits 0.62
7v89.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
 0.70 99.28 0.87 1-615
12-1208		 EM 0.00 hetero-3-3-mer 14 x NAG, 43 x NAG-NAG BLAST / HHblits 0.62
7v8a.1
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
 0.71 99.28 0.87 1-615
12-1208		 EM 0.00 hetero-3-3-mer 16 x NAG, 38 x NAG-NAG BLAST / HHblits 0.62
7v8b.1
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.30 99.28 0.87 1-615
12-1208		 EM 0.00 hetero-1-1-mer 3 x NAG, 1 x NAG-NAG-BMA, 4 x NAG-NAG BLAST / HHblits 0.62
8dlm.1
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
 0.65 99.00 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
8dlm.1
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
 0.74 99.00 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
8dlm.1
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
 0.64 99.00 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
8dln.1
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.33 99.00 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
8dlj.1
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
 0.65 99.06 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG HHblits 0.62
8dlj.1
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
 0.74 99.06 0.87 19-615
1-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG HHblits 0.62
8dlk.1
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.33 99.06 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7v7z.1
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
 0.69 99.23 0.87 1-615
12-1208		 EM 0.00 hetero-3-3-mer 17 x NAG, 31 x NAG-NAG BLAST / HHblits 0.62
7v80.1
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.28 99.23 0.87 1-615
12-1208		 EM 0.00 hetero-1-1-mer 5 x NAG, 3 x NAG-NAG BLAST / HHblits 0.62
8dlp.1
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2
 0.74 98.84 0.87 19-615
1-1208		 EM 0.00 hetero-3-3-mer 42 x NAG, 18 x NAG-NAG HHblits 0.62
8dlq.1
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.33 98.84 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
8dlu.1
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
 0.74 99.06 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 36 x NAG, 18 x NAG-NAG HHblits 0.62
8dlv.1
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.32 99.06 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
✓
 7kj2.1
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
 0.72 99.67 0.87 12-615
14-1208		 EM 0.00 hetero-3-1-mer 36 x NAG, 17 x NAG-NAG BLAST / HHblits 0.62
7kj2.1
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
 0.71 99.67 0.87 12-615
14-1208		 EM 0.00 hetero-3-1-mer 36 x NAG, 17 x NAG-NAG BLAST / HHblits 0.62
7kj2.1
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
 0.71 99.67 0.87 12-615
14-1208		 EM 0.00 hetero-3-1-mer 36 x NAG, 17 x NAG-NAG BLAST / HHblits 0.62
7r10.1
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2
 0.51 99.22 0.87 19-613
1-1208		 EM 0.00 hetero-1-1-mer 1 x ZN, 7 x NAG HHblits 0.62
7r0z.1
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
 0.34 99.17 0.87 19-613
1-1208		 EM 0.00 hetero-1-1-mer 1 x ZN, 8 x NAG HHblits 0.62
7kj3.1
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound
 0.72 99.67 0.87 13-615
14-1208		 EM 0.00 hetero-3-2-mer 40 x NAG, 20 x NAG-NAG HHblits 0.62
7kj3.1
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound
 0.71 99.67 0.87 13-615
14-1208		 EM 0.00 hetero-3-2-mer 40 x NAG, 20 x NAG-NAG HHblits 0.62
7kj4.1
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound
 0.71 99.67 0.87 13-615
14-1208		 EM 0.00 hetero-3-3-mer 42 x NAG, 24 x NAG-NAG HHblits 0.62
7r1a.1
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2
 0.70 99.17 0.87 19-613
1-1208		 EM 0.00 hetero-3-3-mer 48 x NAG, 3 x ZN, 3 x NAG-NAG HHblits 0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.67 99.39 0.87 1-615
16-1208		 EM 0.00 hetero-3-3-mer 26 x NAG, 29 x NAG-NAG BLAST / HHblits 0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.67 99.39 0.87 1-615
16-1208		 EM 0.00 hetero-3-3-mer 26 x NAG, 29 x NAG-NAG BLAST / HHblits 0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.68 99.39 0.87 1-615
16-1208		 EM 0.00 hetero-3-3-mer 26 x NAG, 29 x NAG-NAG BLAST / HHblits 0.62
7tew.1
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.33 99.06 0.87 19-615
1-1206		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
7tex.1
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2
 0.65 99.06 0.87 19-615
1-1206		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
7tex.1
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2
 0.74 99.06 0.87 19-615
1-1206		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.62
8aqs.1
BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
 0.30 97.68 0.87 19-620
1-1212		 EM 0.00 hetero-1-1-mer 6 x NAG, 1 x ZN HHblits 0.61
7r11.1
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
 0.33 99.00 0.87 19-613
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG, 1 x ZN HHblits 0.62
7vx4.1
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex
 0.31 98.95 0.87 17-615
1-1206		 EM 3.90 hetero-1-1-mer 1 x ZN, 5 x NAG HHblits 0.62
7vxd.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
 0.69 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxd.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
 0.68 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxd.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
 0.67 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxf.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
 0.69 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxf.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
 0.69 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxk.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
 0.69 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxk.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
 0.70 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxm.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
 0.69 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vxm.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
 0.69 98.95 0.87 17-615
1-1206		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vx5.1
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex
 0.31 99.39 0.86 17-615
12-1208		 EM 0.00 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST / HHblits 0.62
7vxa.1
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
 0.70 99.39 0.86 17-615
12-1208		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vxa.1
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
 0.70 99.39 0.86 17-615
12-1208		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vxb.1
SARS-CoV-2 Kappa variant spike protein in C2b state
 0.71 99.39 0.86 17-615
12-1208		 EM 3.90 hetero-3-1-mer BLAST / HHblits 0.62
7vxb.1
SARS-CoV-2 Kappa variant spike protein in C2b state
 0.71 99.39 0.86 17-615
12-1208		 EM 3.90 hetero-3-1-mer BLAST / HHblits 0.62
7vxc.1
SARS-CoV-2 Kappa variant spike protein in C3 state
 0.70 99.39 0.86 17-615
12-1208		 EM 3.90 hetero-3-1-mer BLAST / HHblits 0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.67 99.06 0.87 1-615
16-1207		 EM 0.00 hetero-3-3-mer 26 x NAG, 29 x NAG-NAG HHblits 0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.66 99.06 0.87 1-615
16-1207		 EM 0.00 hetero-3-3-mer 26 x NAG, 29 x NAG-NAG HHblits 0.62
7edj.1
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
 0.67 99.06 0.87 1-615
16-1207		 EM 0.00 hetero-3-3-mer 26 x NAG, 29 x NAG-NAG HHblits 0.62
7w98.1
SARS-CoV-2 Delta S-ACE2-C1
 0.70 99.33 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7w99.1
SARS-CoV-2 Delta S-ACE2-C2a
 0.70 99.33 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7w9b.1
SARS-CoV-2 Delta S-ACE2-C2b
 0.70 99.33 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7w9c.1
SARS-CoV-2 Delta S-ACE2-C3
 0.70 99.33 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
8dlu.1
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
 0.75 99.28 0.86 19-615
12-1208		 EM 0.00 hetero-3-2-mer 36 x NAG, 18 x NAG-NAG BLAST / HHblits 0.62
7tez.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.32 99.16 0.86 19-615
12-1208		 EM 0.00 hetero-1-1-mer 7 x NAG BLAST / HHblits 0.62
7tf0.1
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
 0.66 99.16 0.86 19-615
12-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG BLAST / HHblits 0.62
7kmb.1
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4
 0.29 99.72 0.86 20-614
16-1208		 EM 0.00 hetero-1-1-mer 5 x NAG, 2 x NAG-NAG HHblits 0.62
8dlj.1
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
 0.74 99.11 0.86 19-615
12-1208		 EM 0.00 hetero-3-1-mer 28 x NAG, 18 x NAG-NAG BLAST / HHblits 0.62
7r10.1
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2
 0.51 99.55 0.86 19-613
12-1208		 EM 0.00 hetero-1-1-mer 1 x ZN, 7 x NAG BLAST / HHblits 0.62
7r11.1
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
 0.32 99.27 0.86 19-613
12-1208		 EM 0.00 hetero-1-1-mer 7 x NAG, 1 x ZN BLAST / HHblits 0.62
7vx4.1
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex
 0.31 99.22 0.86 17-615
12-1206		 EM 3.90 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST / HHblits 0.62
7vxd.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
 0.68 99.22 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vxf.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
 0.68 99.22 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vxk.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
 0.71 99.22 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vxk.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
 0.69 99.22 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vxm.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
 0.69 99.22 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vxm.1
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
 0.70 99.22 0.86 17-615
12-1206		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
8dm5.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2
 0.74 97.83 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 33 x NAG, 18 x NAG-NAG HHblits 0.61
8dm5.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2
 0.74 97.83 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 33 x NAG, 18 x NAG-NAG HHblits 0.61
8dm6.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.32 97.83 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.61
7tew.1
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.32 99.11 0.86 19-615
12-1206		 EM 0.00 hetero-1-1-mer 7 x NAG BLAST / HHblits 0.62
8aqs.1
BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
 0.29 97.94 0.87 19-620
12-1208		 EM 0.00 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.61
7wk6.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/ACE2)
 0.31 97.45 0.87 17-615
1-1208		 EM 0.00 hetero-1-1-mer HHblits 0.61
7wvp.1
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state
 0.64 97.45 0.87 17-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.61
7wvp.1
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state
 0.64 97.45 0.87 17-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.61
7wvq.1
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
 0.62 97.45 0.87 17-615
1-1208		 EM 0.00 hetero-3-1-mer HHblits 0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
 0.70 97.44 0.87 19-614
1-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG BLAST / HHblits 0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
 0.70 97.44 0.87 19-614
1-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG BLAST / HHblits 0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
 0.70 97.44 0.86 20-613
1-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG HHblits 0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
 0.70 97.44 0.86 20-613
1-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG HHblits 0.61
7wk4.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
 0.67 97.44 0.87 17-615
1-1205		 EM 0.00 hetero-3-1-mer HHblits 0.61
7wk4.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
 0.67 97.44 0.87 17-615
1-1205		 EM 0.00 hetero-3-1-mer HHblits 0.61
7wk5.1
Cryo-EM structure of Omicron S-ACE2, C2 state
 0.64 97.44 0.87 17-615
1-1205		 EM 0.00 hetero-3-1-mer HHblits 0.61
7wk5.1
Cryo-EM structure of Omicron S-ACE2, C2 state
 0.64 97.44 0.87 17-615
1-1205		 EM 0.00 hetero-3-1-mer HHblits 0.61
7t9k.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
 0.74 97.22 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 34 x NAG, 18 x NAG-NAG HHblits 0.61
7t9k.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
 0.65 97.22 0.87 19-615
1-1208		 EM 0.00 hetero-3-2-mer 34 x NAG, 18 x NAG-NAG HHblits 0.61
7t9l.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
 0.33 97.22 0.87 19-615
1-1208		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.61
7ws8.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.73 97.22 0.86 19-613
1-1208		 EM 0.00 hetero-3-2-mer 20 x NAG, 14 x NAG-NAG BLAST / HHblits 0.61
7ws9.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.73 97.22 0.86 19-613
1-1208		 EM 0.00 hetero-3-1-mer 12 x NAG, 14 x NAG-NAG BLAST / HHblits 0.61
7ws8.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.73 97.22 0.86 20-613
1-1208		 EM 0.00 hetero-3-2-mer 20 x NAG, 14 x NAG-NAG HHblits 0.61
7ws9.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.73 97.22 0.86 20-613
1-1208		 EM 0.00 hetero-3-1-mer 12 x NAG, 14 x NAG-NAG HHblits 0.61
7wk6.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/ACE2)
 0.31 98.04 0.86 17-615
12-1208		 EM 0.00 hetero-1-1-mer BLAST / HHblits 0.61
7wvq.1
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
 0.61 98.04 0.86 17-615
12-1208		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
 0.70 97.99 0.86 19-614
12-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG BLAST 0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
 0.70 97.99 0.86 19-614
12-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG BLAST 0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
 0.70 98.15 0.86 19-614
14-1208		 EM 0.00 hetero-3-3-mer 33 x NAG, 3 x ZN, 15 x NAG-NAG BLAST 0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
 0.70 98.15 0.86 19-614
14-1208		 EM 0.00 hetero-3-3-mer 33 x NAG, 3 x ZN, 15 x NAG-NAG BLAST 0.61
7wk4.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
 0.67 98.04 0.86 17-615
12-1205		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.61
7wk4.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
 0.67 98.04 0.86 17-615
12-1205		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.61
7wk5.1
Cryo-EM structure of Omicron S-ACE2, C2 state
 0.64 98.04 0.86 17-615
12-1205		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.61
7wk5.1
Cryo-EM structure of Omicron S-ACE2, C2 state
 0.64 98.04 0.86 17-615
12-1205		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.61
7t9k.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
 0.74 97.82 0.86 19-615
12-1208		 EM 0.00 hetero-3-2-mer 34 x NAG, 18 x NAG-NAG BLAST / HHblits 0.61
7t9k.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
 0.65 97.82 0.86 19-615
12-1208		 EM 0.00 hetero-3-2-mer 34 x NAG, 18 x NAG-NAG BLAST / HHblits 0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
 0.70 97.98 0.86 20-613
12-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG BLAST / HHblits 0.61
7y9z.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
 0.70 97.98 0.86 20-613
12-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG BLAST / HHblits 0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
 0.70 98.15 0.86 20-613
14-1208		 EM 0.00 hetero-3-3-mer 33 x NAG, 3 x ZN, 15 x NAG-NAG BLAST / HHblits 0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
 0.70 98.15 0.86 20-613
14-1208		 EM 0.00 hetero-3-3-mer 33 x NAG, 3 x ZN, 15 x NAG-NAG BLAST / HHblits 0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
 0.70 97.98 0.86 19-614
14-1208		 EM 0.00 hetero-3-2-mer 24 x NAG, 2 x ZN, 23 x NAG-NAG BLAST 0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
 0.71 97.98 0.86 19-614
14-1208		 EM 0.00 hetero-3-2-mer 24 x NAG, 2 x ZN, 23 x NAG-NAG BLAST 0.61
7ws8.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.73 97.82 0.86 19-613
12-1208		 EM 0.00 hetero-3-2-mer 20 x NAG, 14 x NAG-NAG BLAST 0.61
7ws9.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.73 97.82 0.86 19-613
12-1208		 EM 0.00 hetero-3-1-mer 12 x NAG, 14 x NAG-NAG BLAST 0.61
7ws8.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.73 97.82 0.86 20-613
12-1208		 EM 0.00 hetero-3-2-mer 20 x NAG, 14 x NAG-NAG BLAST / HHblits 0.61
7ws9.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.73 97.82 0.86 20-613
12-1208		 EM 0.00 hetero-3-1-mer 12 x NAG, 14 x NAG-NAG BLAST / HHblits 0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
 0.70 97.98 0.86 20-613
14-1208		 EM 0.00 hetero-3-2-mer 24 x NAG, 2 x ZN, 23 x NAG-NAG BLAST / HHblits 0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
 0.71 97.98 0.86 20-613
14-1208		 EM 0.00 hetero-3-2-mer 24 x NAG, 2 x ZN, 23 x NAG-NAG BLAST / HHblits 0.61
8aqt.1
Beta SARS-CoV-2 Spike bound to mouse ACE2 (local)
 0.16 93.22 0.87 19-623
1-1212		 EM 0.00 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG HHblits 0.60
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
 0.70 97.59 0.86 19-614
14-1208		 EM 0.00 hetero-3-3-mer 33 x NAG, 3 x ZN, 15 x NAG-NAG BLAST / HHblits 0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
 0.70 97.59 0.86 19-614
14-1208		 EM 0.00 hetero-3-3-mer 33 x NAG, 3 x ZN, 15 x NAG-NAG BLAST / HHblits 0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
 0.70 97.59 0.86 20-613
14-1208		 EM 0.00 hetero-3-3-mer 33 x NAG, 3 x ZN, 15 x NAG-NAG HHblits 0.61
7ya0.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
 0.70 97.59 0.86 20-613
14-1208		 EM 0.00 hetero-3-3-mer 33 x NAG, 3 x ZN, 15 x NAG-NAG HHblits 0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
 0.70 97.42 0.86 19-614
14-1208		 EM 0.00 hetero-3-2-mer 24 x NAG, 2 x ZN, 23 x NAG-NAG BLAST / HHblits 0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
 0.71 97.42 0.86 19-614
14-1208		 EM 0.00 hetero-3-2-mer 24 x NAG, 2 x ZN, 23 x NAG-NAG BLAST / HHblits 0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
 0.70 97.42 0.86 20-613
14-1208		 EM 0.00 hetero-3-2-mer 24 x NAG, 2 x ZN, 23 x NAG-NAG HHblits 0.61
7xch.1
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
 0.71 97.42 0.86 20-613
14-1208		 EM 0.00 hetero-3-2-mer 24 x NAG, 2 x ZN, 23 x NAG-NAG HHblits 0.61
8dm7.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2
 0.73 92.63 0.88 1-615
1-1208		 EM 0.00 hetero-3-2-mer 25 x NAG, 18 x NAG-NAG HHblits 0.59
8dm8.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2)
 0.31 92.63 0.88 1-615
1-1208		 EM 0.00 hetero-1-1-mer 3 x NAG HHblits 0.59
8aqv.1
BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
 0.28 92.22 0.87 19-623
1-1212		 EM 0.00 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG HHblits 0.59
8aqt.1
Beta SARS-CoV-2 Spike bound to mouse ACE2 (local)
 0.17 93.66 0.87 19-623
12-1208		 EM 0.00 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG BLAST / HHblits 0.60
8dm9.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
 0.73 92.02 0.87 1-615
1-1208		 EM 0.00 hetero-3-1-mer 26 x NAG, 18 x NAG-NAG HHblits 0.59
8dma.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2)
 0.32 92.02 0.87 1-615
1-1208		 EM 0.00 hetero-1-1-mer 3 x NAG HHblits 0.59
8dm7.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2
 0.74 92.70 0.87 1-615
12-1208		 EM 0.00 hetero-3-2-mer 25 x NAG, 18 x NAG-NAG BLAST / HHblits 0.59
8aqw.1
BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
 0.27 92.25 0.87 19-618
1-1212		 EM 0.00 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG HHblits 0.59
8aqu.1
BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
 0.20 91.66 0.87 19-623
1-1212		 EM 0.00 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG HHblits 0.59
8aqv.1
BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
 0.28 92.50 0.87 19-623
12-1208		 EM 0.00 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG BLAST / HHblits 0.59
8aqu.1
BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
 0.20 92.43 0.86 19-623
12-1208		 EM 0.00 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG BLAST / HHblits 0.59
8aqw.1
BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
 0.27 92.69 0.86 19-618
12-1208		 EM 0.00 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG BLAST / HHblits 0.59
7wrh.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
 0.70 0.55 92.55 0.86 18-615
15-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG BLAST 0.59
7wri.1
Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2
 0.29 92.71 0.86 18-615
14-1205		 EM 0.00 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST 0.60
7wrh.1
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
 0.70 91.94 0.86 18-615
15-1208		 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN, 22 x NAG-NAG BLAST / HHblits 0.59
7wri.1
Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2
 0.29 92.10 0.86 18-615
14-1205		 EM 0.00 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.59
7dqa.1
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex
 0.35 99.90 0.48 1-805
335-526		 EM 0.00 hetero-1-1-mer 1 x ZN, 5 x NAG HHblits 0.62
7vx9.1
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
 0.70 99.65 0.83 19-615
14-1146		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vx9.1
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
 0.69 99.65 0.83 19-615
14-1146		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.62
7vx9.1
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
 0.70 99.65 0.83 20-614
14-1146		 EM 0.00 hetero-3-1-mer HHblits 0.62
7vx9.1
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
 0.69 99.65 0.83 20-614
14-1146		 EM 0.00 hetero-3-1-mer HHblits 0.62
7dqa.1
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex
 0.35 99.90 0.48 1-805
333-526		 EM 0.00 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST / HHblits 0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 99.40 0.48 1-805
329-529		 X-ray 2.70 hetero-1-1-mer 2 x ZN, 13 x NAG, 2 x NAG-NAG HHblits 0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 99.40 0.48 1-805
329-529		 X-ray 2.70 hetero-1-1-mer 2 x ZN, 13 x NAG, 2 x NAG-NAG HHblits 0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 99.40 0.48 1-805
329-529		 X-ray 2.70 hetero-1-1-mer 2 x ZN, 13 x NAG, 2 x NAG-NAG HHblits 0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 99.40 0.48 1-805
329-529		 X-ray 2.70 hetero-1-1-mer 2 x ZN, 13 x NAG, 2 x NAG-NAG HHblits 0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 99.70 0.48 1-805
328-529		 X-ray 2.70 hetero-1-1-mer 2 x ZN, 13 x NAG, 2 x NAG-NAG BLAST / HHblits 0.62
8df5.1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 99.70 0.48 1-805
328-529		 X-ray 2.70 hetero-1-1-mer 2 x ZN, 13 x NAG, 2 x NAG-NAG BLAST / HHblits 0.62
7l7f.1
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1
 0.38 0.33 98.92 0.49 1-805
319-532		 EM 0.00 hetero-2-2-mer HHblits 0.62
6m17.1
The 2019-nCoV RBD/ACE2-B0AT1 complex
 0.41 99.90 0.49 2-805
319-541		 EM 0.00 hetero-2-2-mer 10 x NAG, 2 x LEU, 2 x ZN, 14 x NAG-NAG, 2 x NAG-NAG-NAG HHblits 0.62
6m17.1
The 2019-nCoV RBD/ACE2-B0AT1 complex
 0.41 100.00 0.49 2-805
319-541		 EM 0.00 hetero-2-2-mer 10 x NAG, 2 x LEU, 2 x ZN, 14 x NAG-NAG, 2 x NAG-NAG-NAG BLAST / HHblits 0.62
7y75.1
SIT1-ACE2-BA.2 RBD
 0.41 0.25 98.44 0.49 2-805
319-541		 EM 0.00 hetero-2-2-mer 6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAG HHblits 0.62
7y76.1
SIT1-ACE2-BA.5 RBD
 0.41 98.34 0.49 2-805
319-541		 EM 0.00 hetero-2-2-mer 6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAG HHblits 0.62
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
 0.63 0.52 84.55 0.86 19-615
1-1214		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.57
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
 0.64 84.55 0.86 19-615
1-1214		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.57
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
 0.63 84.54 0.86 20-615
1-1214		 EM 0.00 hetero-3-1-mer HHblits 0.57
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
 0.64 84.54 0.86 20-615
1-1214		 EM 0.00 hetero-3-1-mer HHblits 0.57
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
 0.62 85.26 0.85 19-615
26-1214		 EM 0.00 hetero-3-1-mer BLAST 0.58
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
 0.63 85.26 0.85 19-615
26-1214		 EM 0.00 hetero-3-1-mer BLAST 0.58
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
 0.62 85.25 0.85 20-615
26-1214		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.58
6acg.1
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
 0.63 85.25 0.85 20-615
26-1214		 EM 0.00 hetero-3-1-mer BLAST / HHblits 0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.61 85.04 0.85 19-615
26-1208		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST 0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.68 85.04 0.85 19-615
26-1208		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST 0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.61 85.04 0.85 19-615
26-1208		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST 0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.60 84.73 0.85 19-615
25-1212		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST / HHblits 0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.67 84.73 0.85 19-615
25-1212		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST / HHblits 0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.60 84.73 0.85 19-615
25-1212		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST / HHblits 0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.61 85.03 0.85 20-615
26-1208		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST / HHblits 0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.68 85.03 0.85 20-615
26-1208		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST / HHblits 0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.61 85.03 0.85 20-615
26-1208		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN BLAST / HHblits 0.58
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.60 84.72 0.85 20-615
25-1212		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN HHblits 0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.67 84.72 0.85 20-615
25-1212		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN HHblits 0.57
6cs2.1
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
 0.60 84.72 0.85 20-615
25-1212		 EM 0.00 hetero-3-1-mer 6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MAN HHblits 0.57
7wsg.1
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with sea lion ACE2
 0.32 81.13 0.47 1-804
335-516		 EM 0.00 hetero-1-1-mer 1 x ZN HHblits 0.56
7wsh.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2
 0.34 86.56 0.48 1-804
335-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 1 x NAG HHblits 0.58
7wsh.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2
 0.34 0.51 86.59 0.48 1-804
333-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.58
7xby.1
The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2
 0.34 87.82 0.49 1-805
319-541		 X-ray 2.85 hetero-1-1-mer 1 x ZN, 6 x BR, 1 x NAG HHblits 0.58
7xby.1
The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2
 0.35 0.50 88.23 0.49 1-805
319-541		 X-ray 2.85 hetero-1-1-mer 1 x ZN, 6 x BR, 1 x NAG BLAST / HHblits 0.59
7wnm.1
Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q)
 0.36 99.38 0.46 1-740
319-541		 X-ray 2.70 hetero-1-1-mer 1 x ZN, 1 x NAG HHblits 0.62
7wnm.1
Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q)
 0.36 99.48 0.46 1-740
319-541		 X-ray 2.70 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.62
7wsf.1
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with minke whale ACE2
 0.35 81.10 0.44 1-740
335-516		 EM 0.00 hetero-1-1-mer 1 x ZN HHblits 0.56
7wse.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
 0.35 86.91 0.45 1-740
335-527		 EM 0.00 hetero-1-1-mer 1 x ZN HHblits 0.58
7wse.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
 0.35 86.94 0.45 1-740
333-527		 EM 0.00 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.58
7wsf.1
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with minke whale ACE2
 0.35 81.20 0.43 12-740
335-516		 EM 0.00 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.56
7c8d.1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
 0.35 88.97 0.44 18-740
335-527		 EM 0.00 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.59
7c8d.1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
 0.35 0.58 89.00 0.44 18-740
333-527		 EM 0.00 hetero-1-1-mer 1 x ZN BLAST 0.59
7c8d.1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
 0.35 88.96 0.44 19-740
335-527		 EM 0.00 hetero-1-1-mer 1 x ZN HHblits 0.59
7c8d.1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
 0.35 88.99 0.44 19-740
333-527		 EM 0.00 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.59
7wse.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
 0.35 87.08 0.44 12-740
335-527		 EM 0.00 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.58
7wse.1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
 0.35 0.62 87.11 0.44 12-740
333-527		 EM 0.00 hetero-1-1-mer 1 x ZN BLAST 0.58
7e3j.1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
 0.38 87.98 0.44 18-740
335-527		 X-ray 2.99 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.59
7e3j.1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
 0.39 0.56 88.00 0.44 18-740
333-527		 X-ray 2.99 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST 0.59
7e3j.1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
 0.38 87.65 0.44 19-740
335-527		 X-ray 2.99 hetero-1-1-mer 1 x ZN, 1 x NAG HHblits 0.59
7e3j.1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
 0.38 87.68 0.44 19-740
333-527		 X-ray 2.99 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.59
7c8j.1
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
 0.37 84.78 0.43 20-726
335-527		 X-ray 3.18 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.58
7c8j.1
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
 0.37 0.51 84.81 0.43 20-726
333-527		 X-ray 3.18 hetero-1-1-mer 1 x ZN BLAST 0.58
7c8j.1
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
 0.37 84.76 0.43 21-726
335-527		 X-ray 3.18 hetero-1-1-mer 1 x ZN HHblits 0.58
7c8j.1
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
 0.37 84.79 0.43 21-726
333-527		 X-ray 3.18 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.58
7wpo.1
Structure of NeoCOV RBD binding to Bat37 ACE2
 0.34 67.10 0.41 20-714
330-497		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-FUC BLAST / HHblits 0.51
7wpo.1
Structure of NeoCOV RBD binding to Bat37 ACE2
 0.34 66.82 0.41 21-714
330-497		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.50
7a91.1
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
 0.41 100.00 0.61 19-613
1-679		 EM 0.00 hetero-1-1-mer 7 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.63
7a92.1
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement)
 0.53 100.00 0.61 19-613
1-676		 EM 0.00 hetero-1-1-mer 7 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.63
7fdg.1
SARS-COV-2 Spike RBDMACSp6 binding to hACE2
 0.35 99.88 0.39 1-615
333-526		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
7fdh.1
SARS-COV-2 Spike RBDMACSp25 binding to hACE2
 0.36 99.75 0.39 1-615
333-526		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
7fdi.1
SARS-COV-2 Spike RBDMACSp36 binding to hACE2
 0.36 99.63 0.39 1-615
333-526		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
7fdg.1
SARS-COV-2 Spike RBDMACSp6 binding to hACE2
 0.35 99.63 0.39 1-615
332-526		 EM 0.00 hetero-1-1-mer 5 x NAG HHblits 0.63
7fdh.1
SARS-COV-2 Spike RBDMACSp25 binding to hACE2
 0.36 99.51 0.39 1-615
332-526		 EM 0.00 hetero-1-1-mer 5 x NAG HHblits 0.63
7fdi.1
SARS-COV-2 Spike RBDMACSp36 binding to hACE2
 0.36 99.38 0.39 1-615
332-526		 EM 0.00 hetero-1-1-mer 5 x NAG HHblits 0.63
7sn0.1
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
 0.37 99.16 0.40 1-615
319-541		 X-ray 3.08 hetero-1-1-mer 1 x ZN, 1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAG-GAL, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG, 1 x NAG-NAG HHblits 0.62
7sn0.2
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
 0.36 99.16 0.40 1-615
319-541		 X-ray 3.08 hetero-1-1-mer 1 x ZN, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAG HHblits 0.62
7sn0.1
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
 0.37 99.28 0.40 1-615
319-541		 X-ray 3.08 hetero-1-1-mer 1 x ZN, 1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAG-GAL, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG, 1 x NAG-NAG BLAST / HHblits 0.62
7sn0.2
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
 0.36 99.28 0.40 1-615
319-541		 X-ray 3.08 hetero-1-1-mer 1 x ZN, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAG BLAST / HHblits 0.62
2ajf.1
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor
 0.33 93.48 0.37 19-615
336-516		 X-ray 2.90 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG-BMA BLAST / HHblits 0.61
3scj.1
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human receptor ACE2
 0.33 93.48 0.37 19-615
336-516		 X-ray 3.00 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.61
3scj.1
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human receptor ACE2
 0.33 93.47 0.37 20-615
336-516		 X-ray 3.00 hetero-1-1-mer 1 x ZN HHblits 0.61
2ajf.1
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor
 0.33 93.46 0.37 20-614
336-516		 X-ray 2.90 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG-BMA HHblits 0.61
7w9i.1
SARS-CoV-2 Delta S-RBD-ACE2
 0.34 98.86 0.38 17-615
335-526		 EM 0.00 hetero-1-1-mer HHblits 0.62
7w9i.1
SARS-CoV-2 Delta S-RBD-ACE2
 0.36 99.75 0.38 17-615
333-526		 EM 0.00 hetero-1-1-mer BLAST / HHblits 0.63
7dx4.1
The structure of FC08 Fab-hA.CE2-RBD complex
 0.36 100.00 0.38 19-615
335-526		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
7ydi.1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region
 0.34 100.00 0.38 19-615
335-526		 EM 0.00 hetero-1-1-mer 1 x ZN, 4 x NAG BLAST / HHblits 0.63
3d0g.1
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus human strain complexed with human-civet chimeric receptor ACE2
 0.33 0.16 92.35 0.37 19-615
337-516		 X-ray 2.80 hetero-2-2-mer 5 x NDG, 2 x ZN, 1 x NAG BLAST / HHblits 0.60
7ydi.1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region
 0.34 100.00 0.38 19-615
334-526		 EM 0.00 hetero-1-1-mer 1 x ZN, 4 x NAG BLAST 0.63
7dx4.1
The structure of FC08 Fab-hA.CE2-RBD complex
 0.36 100.00 0.38 19-615
333-526		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST 0.63
3sck.1
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2
 0.33 92.22 0.37 19-615
337-516		 X-ray 3.00 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.60
7nxc.1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
 0.36 99.49 0.38 19-615
335-528		 X-ray 3.14 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
7whh.1
Crystal structure of SARS-CoV-2 omicron RBD and human ACE2
 0.35 0.56 97.72 0.38 19-615
335-526		 X-ray 2.60 hetero-1-1-mer 1 x ZN, 4 x NAG, 1 x NAG-FUC-NAG BLAST / HHblits 0.62
3sck.1
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2
 0.33 92.21 0.37 20-615
337-516		 X-ray 3.00 hetero-1-1-mer 1 x ZN HHblits 0.60
7nxc.1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
 0.36 99.50 0.38 19-615
333-528		 X-ray 3.14 hetero-1-1-mer 5 x NAG BLAST 0.63
7vib.1
Crystal structure of human ACE2 and GX/P2V RBD
 0.35 0.60 96.83 0.38 19-615
335-526		 X-ray 3.20 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.62
7vib.2
Crystal structure of human ACE2 and GX/P2V RBD
 0.34 96.83 0.38 19-615
335-526		 X-ray 3.20 hetero-1-1-mer 1 x ZN BLAST / HHblits 0.62
7nxc.1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
 0.36 99.49 0.38 20-615
335-528		 X-ray 3.14 hetero-1-1-mer 5 x NAG HHblits 0.63
7dx4.1
The structure of FC08 Fab-hA.CE2-RBD complex
 0.36 100.00 0.38 20-614
335-526		 EM 0.00 hetero-1-1-mer 5 x NAG HHblits 0.63
7bh9.1
SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain
 0.35 98.87 0.38 19-615
333-528		 EM 0.00 hetero-1-1-mer 1 x ZN, 3 x NAG BLAST / HHblits 0.63
7pki.1
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
 0.35 99.24 0.38 19-614
335-528		 X-ray 2.94 hetero-1-1-mer 6 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.63
7whh.1
Crystal structure of SARS-CoV-2 omicron RBD and human ACE2
 0.35 97.71 0.38 19-614
335-526		 X-ray 2.60 hetero-1-1-mer 1 x ZN, 4 x NAG, 1 x NAG-FUC-NAG HHblits 0.62
3d0g.1
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus human strain complexed with human-civet chimeric receptor ACE2
 0.33 0.16 92.33 0.37 20-614
337-516		 X-ray 2.80 hetero-2-2-mer 5 x NDG, 2 x ZN, 1 x NAG HHblits 0.60
7ya1.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
 0.34 0.62 98.10 0.38 19-614
335-527		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.62
7xb1.1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
 0.34 0.55 97.72 0.38 19-614
335-527		 X-ray 2.70 hetero-1-1-mer 1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA BLAST / HHblits 0.62
7wbl.1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
 0.34 97.72 0.38 19-614
335-527		 EM 0.00 hetero-1-1-mer 4 x NAG, 1 x ZN BLAST / HHblits 0.62
7xci.1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
 0.35 97.72 0.38 19-614
335-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 6 x NAG, 1 x NAG-NAG BLAST / HHblits 0.62
7xcp.1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
 0.35 97.72 0.38 19-614
335-527		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.62
7lo4.1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
 0.36 99.87 0.38 19-614
335-530		 X-ray 2.47 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG-FUC BLAST / HHblits 0.63
7nxc.1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
 0.36 99.49 0.38 20-615
333-528		 X-ray 3.14 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
7dx4.1
The structure of FC08 Fab-hA.CE2-RBD complex
 0.36 100.00 0.38 20-614
333-526		 EM 0.00 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
7ya1.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
 0.34 0.62 98.48 0.38 19-614
333-527		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST 0.62
7pki.1
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
 0.35 99.24 0.38 19-614
332-528		 X-ray 2.94 hetero-1-1-mer 6 x NAG, 1 x ZN, 1 x NAG-NAG BLAST 0.63
7lo4.1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
 0.36 99.87 0.38 19-614
333-530		 X-ray 2.47 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG-FUC BLAST 0.63
7xb1.1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
 0.34 98.10 0.38 19-614
333-527		 X-ray 2.70 hetero-1-1-mer 1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA BLAST 0.62
7wbl.1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
 0.35 98.10 0.38 19-614
333-527		 EM 0.00 hetero-1-1-mer 4 x NAG, 1 x ZN BLAST 0.62
7xci.1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
 0.35 98.10 0.38 19-614
333-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 6 x NAG, 1 x NAG-NAG BLAST 0.62
7xcp.1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
 0.35 98.10 0.38 19-614
333-527		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST 0.62
7l0n.1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
 0.35 99.88 0.38 19-615
328-530		 X-ray 2.78 hetero-1-1-mer 1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC BLAST / HHblits 0.63
7vib.1
Crystal structure of human ACE2 and GX/P2V RBD
 0.35 96.82 0.38 20-614
335-526		 X-ray 3.20 hetero-1-1-mer 1 x ZN HHblits 0.62
7vib.2
Crystal structure of human ACE2 and GX/P2V RBD
 0.34 0.53 96.82 0.38 20-614
335-526		 X-ray 3.20 hetero-1-1-mer 1 x ZN HHblits 0.62
7pki.1
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
 0.35 99.24 0.38 20-613
335-528		 X-ray 2.94 hetero-1-1-mer 6 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.63
7l0n.1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
 0.35 99.88 0.39 19-615
328-531		 X-ray 2.78 hetero-1-1-mer 1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC BLAST 0.63
7ya1.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
 0.34 0.62 98.09 0.38 20-613
335-527		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.62
7xb1.1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
 0.34 97.71 0.38 20-613
335-527		 X-ray 2.70 hetero-1-1-mer 1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA HHblits 0.62
7wbl.1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
 0.34 97.71 0.38 20-613
335-527		 EM 0.00 hetero-1-1-mer 4 x NAG, 1 x ZN HHblits 0.62
7xci.1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
 0.35 97.71 0.38 20-613
335-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 6 x NAG, 1 x NAG-NAG HHblits 0.62
7xcp.1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
 0.35 97.71 0.38 20-613
335-527		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.62
7lo4.1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
 0.36 99.87 0.38 20-613
335-530		 X-ray 2.47 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG-FUC HHblits 0.63
7xaz.1
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
 0.35 97.58 0.38 20-613
335-527		 X-ray 3.00 hetero-1-1-mer 6 x NAG, 1 x ZN HHblits 0.62
7xaz.2
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
 0.35 97.58 0.38 20-613
335-527		 X-ray 3.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.62
7xb0.1
Crystal structure of Omicron BA.2 RBD complexed with hACE2
 0.34 97.97 0.38 20-613
335-527		 X-ray 2.90 hetero-1-1-mer 1 x ZN, 3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG HHblits 0.62
7ya1.1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
 0.34 0.62 98.48 0.38 20-613
333-527		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.62
7pki.1
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
 0.35 99.24 0.38 20-613
332-528		 X-ray 2.94 hetero-1-1-mer 6 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.63
7lo4.1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
 0.36 99.87 0.38 20-613
333-530		 X-ray 2.47 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG-FUC BLAST / HHblits 0.63
7xb1.1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
 0.34 98.10 0.38 20-613
333-527		 X-ray 2.70 hetero-1-1-mer 1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA BLAST / HHblits 0.62
7wbl.1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
 0.35 98.10 0.38 20-613
333-527		 EM 0.00 hetero-1-1-mer 4 x NAG, 1 x ZN BLAST / HHblits 0.62
7xci.1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
 0.35 98.10 0.38 20-613
333-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 6 x NAG, 1 x NAG-NAG BLAST / HHblits 0.62
7xcp.1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
 0.35 98.10 0.38 20-613
333-527		 EM 0.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.62
7xaz.1
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
 0.36 97.97 0.38 20-613
333-527		 X-ray 3.00 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.62
7xaz.2
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
 0.36 97.97 0.38 20-613
333-527		 X-ray 3.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.62
7xb0.1
Crystal structure of Omicron BA.2 RBD complexed with hACE2
 0.35 97.97 0.38 20-613
333-527		 X-ray 2.90 hetero-1-1-mer 1 x ZN, 3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG BLAST / HHblits 0.62
7p19.1
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2
 0.36 99.88 0.39 19-615
334-541		 X-ray 3.24 hetero-1-1-mer 3 x NAG, 1 x ZN BLAST / HHblits 0.63
7wsa.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.35 97.73 0.38 19-613
331-529		 EM 0.00 hetero-1-1-mer 7 x NAG BLAST / HHblits 0.62
7tn0.1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 97.25 0.38 19-615
327-531		 X-ray 2.85 hetero-1-1-mer 1 x ZN, 6 x NAG BLAST / HHblits 0.62
7l0n.1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
 0.35 99.87 0.38 20-614
328-530		 X-ray 2.78 hetero-1-1-mer 1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC HHblits 0.63
7l0n.2
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
 0.36 99.87 0.38 20-614
328-530		 X-ray 2.78 hetero-1-1-mer 1 x ZN, 5 x NAG, 1 x NAG-NAG-BMA-MAN-FUC HHblits 0.63
7xbh.1
The complex structure of RshSTT182/200 RBD bound to human ACE2
 0.35 0.63 96.34 0.39 18-619
319-541		 X-ray 3.02 hetero-1-1-mer 5 x NAG, 1 x ZN BLAST 0.62
7zf7.1
SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2
 0.36 98.00 0.38 20-615
330-532		 X-ray 3.46 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.62
7l0n.1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
 0.35 99.87 0.38 20-614
328-531		 X-ray 2.78 hetero-1-1-mer 1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC BLAST / HHblits 0.63
7wsa.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.35 98.12 0.38 19-613
330-530		 EM 0.00 hetero-1-1-mer 7 x NAG BLAST 0.62
7p19.1
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2
 0.35 99.88 0.39 19-614
334-541		 X-ray 3.24 hetero-1-1-mer 3 x NAG, 1 x ZN HHblits 0.63
7p19.2
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2
 0.36 99.88 0.39 19-614
334-541		 X-ray 3.24 hetero-1-1-mer 4 x NAG, 1 x ZN HHblits 0.63
7xwa.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
 0.35 97.04 0.39 19-617
322-536		 X-ray 3.36 hetero-1-1-mer 1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMA BLAST / HHblits 0.62
7xwa.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
 0.35 97.04 0.39 19-617
322-536		 X-ray 3.36 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAG BLAST / HHblits 0.62
6lzg.1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
 0.37 99.88 0.39 19-614
319-527		 X-ray 2.50 hetero-1-1-mer 4 x NAG, 1 x ZN BLAST / HHblits 0.63
7wsa.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.35 97.73 0.38 20-613
331-529		 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.62
6lzg.1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
 0.37 100.00 0.39 19-614
319-527		 X-ray 2.50 hetero-1-1-mer 4 x NAG, 1 x ZN BLAST 0.63
7tn0.1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 97.25 0.38 20-615
327-531		 X-ray 2.85 hetero-1-1-mer 1 x ZN, 6 x NAG HHblits 0.62
7tn0.2
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.36 97.25 0.38 20-615
327-531		 X-ray 2.85 hetero-1-1-mer 5 x NAG, 1 x ZN HHblits 0.62
7tn0.1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 97.76 0.39 19-615
324-531		 X-ray 2.85 hetero-1-1-mer 1 x ZN, 6 x NAG BLAST 0.62
7xwa.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
 0.36 97.91 0.39 19-617
322-536		 X-ray 3.36 hetero-1-1-mer 1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMA BLAST 0.62
7xwa.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
 0.35 97.91 0.39 19-617
322-536		 X-ray 3.36 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAG BLAST 0.62
7ddp.1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
 0.36 96.52 0.39 19-615
319-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST / HHblits 0.62
7wsa.1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.35 98.11 0.38 20-613
330-530		 EM 0.00 hetero-1-1-mer 7 x NAG BLAST / HHblits 0.62
7xwa.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
 0.35 97.03 0.39 20-617
322-536		 X-ray 3.36 hetero-1-1-mer 1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.62
7xwa.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
 0.35 97.03 0.39 20-617
322-536		 X-ray 3.36 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAG HHblits 0.62
7xbh.1
The complex structure of RshSTT182/200 RBD bound to human ACE2
 0.34 0.61 93.89 0.39 18-619
319-541		 X-ray 3.02 hetero-1-1-mer 5 x NAG, 1 x ZN BLAST / HHblits 0.60
7ddp.1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
 0.36 0.57 96.65 0.39 19-615
319-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST 0.62
7tn0.1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
 0.35 97.76 0.39 20-615
324-531		 X-ray 2.85 hetero-1-1-mer 1 x ZN, 6 x NAG BLAST / HHblits 0.62
7xwa.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
 0.36 97.91 0.39 20-617
322-536		 X-ray 3.36 hetero-1-1-mer 1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMA BLAST / HHblits 0.62
7xwa.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
 0.35 97.91 0.39 20-617
322-536		 X-ray 3.36 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAG BLAST / HHblits 0.62
7dmu.1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
 0.35 99.01 0.39 18-615
319-531		 X-ray 3.20 hetero-1-1-mer 1 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-BMA BLAST / HHblits 0.63
6lzg.1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
 0.37 99.88 0.39 20-613
319-527		 X-ray 2.50 hetero-1-1-mer 4 x NAG, 1 x ZN HHblits 0.63
7dmu.1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
 0.36 99.14 0.39 18-615
319-531		 X-ray 3.20 hetero-1-1-mer 1 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-BMA BLAST 0.63
6lzg.1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
 0.37 0.55 100.00 0.39 20-613
319-527		 X-ray 2.50 hetero-1-1-mer 4 x NAG, 1 x ZN BLAST / HHblits 0.63
7efr.1
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y)
 0.36 99.63 0.39 19-615
321-537		 X-ray 2.49 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
7efr.1
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y)
 0.36 99.75 0.39 19-615
321-537		 X-ray 2.49 hetero-1-1-mer 5 x NAG BLAST 0.63
7dmu.2
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
 0.35 99.01 0.39 19-615
319-531		 X-ray 3.20 hetero-1-1-mer 2 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG HHblits 0.63
7ddp.1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
 0.36 96.51 0.39 20-614
319-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 5 x NAG HHblits 0.62
6m0j.1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
 0.37 99.88 0.39 19-615
319-541		 X-ray 2.45 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST / HHblits 0.63
7zdq.1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
 0.35 99.63 0.39 19-615
319-541		 EM 0.00 hetero-1-1-mer 3 x NAG BLAST / HHblits 0.63
7efp.1
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y)
 0.35 99.75 0.39 20-615
320-537		 X-ray 2.70 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.63
6m0j.1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
 0.37 100.00 0.39 19-615
319-541		 X-ray 2.45 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST 0.63
7zdq.1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
 0.36 99.76 0.39 19-615
319-541		 EM 0.00 hetero-1-1-mer 3 x NAG BLAST 0.63
7ddp.1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
 0.36 96.64 0.39 20-614
319-527		 EM 0.00 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST / HHblits 0.62
7efp.1
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y)
 0.35 99.88 0.39 20-615
320-537		 X-ray 2.70 hetero-1-1-mer 5 x NAG BLAST 0.63
6vw1.1
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
 0.36 96.19 0.39 19-615
319-535		 X-ray 2.68 hetero-1-1-mer 1 x ZN, 1 x NAG, 3 x NAG-NAG-BMA, 2 x NAG-NAG BLAST 0.62
6vw1.2
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
 0.35 0.60 96.19 0.39 19-615
319-535		 X-ray 2.68 hetero-1-1-mer 1 x ZN, 2 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-NAG BLAST 0.62
6m0j.1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
 0.37 99.88 0.39 20-615
319-541		 X-ray 2.45 hetero-1-1-mer 1 x ZN, 5 x NAG HHblits 0.63
7ekh.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2
 0.37 0.55 99.76 0.39 20-615
319-541		 X-ray 2.40 hetero-1-1-mer 4 x NAG, 1 x ZN HHblits 0.63
7eke.1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2
 0.37 99.76 0.39 20-615
319-541		 X-ray 2.70 hetero-1-1-mer 4 x NAG, 1 x ZN HHblits 0.63
7ekf.1
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2
 0.37 99.76 0.39 20-615
319-541		 X-ray 2.85 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.63
7zdq.1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
 0.35 99.63 0.39 20-615
319-541		 EM 0.00 hetero-1-1-mer 3 x NAG HHblits 0.63
6m0j.1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
 0.37 100.00 0.39 20-615
319-541		 X-ray 2.45 hetero-1-1-mer 1 x ZN, 5 x NAG BLAST / HHblits 0.63
7ekh.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2
 0.37 99.88 0.39 20-615
319-541		 X-ray 2.40 hetero-1-1-mer 4 x NAG, 1 x ZN BLAST / HHblits 0.63
7eke.1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2
 0.37 99.88 0.39 20-615
319-541		 X-ray 2.70 hetero-1-1-mer 4 x NAG, 1 x ZN BLAST / HHblits 0.63
7ekg.1
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2
 0.37 99.51 0.39 20-615
319-541		 X-ray 2.63 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.63
7ekc.1
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2
 0.37 99.51 0.39 20-615
319-541		 X-ray 2.80 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.63
7zdq.1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
 0.36 99.76 0.39 20-615
319-541		 EM 0.00 hetero-1-1-mer 3 x NAG BLAST / HHblits 0.63
7ekf.1
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2
 0.37 99.88 0.39 20-615
319-541		 X-ray 2.85 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.63
7rpv.1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.35 99.26 0.39 19-615
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.62
7rpv.2
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.34 99.26 0.39 19-615
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.62
7rpv.3
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.36 99.26 0.39 19-615
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.62
7ekg.1
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2
 0.37 99.63 0.39 20-615
319-541		 X-ray 2.63 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.63
7ekc.1
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2
 0.37 99.63 0.39 20-615
319-541		 X-ray 2.80 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.63
7rpv.1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.35 99.39 0.39 19-615
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST 0.63
7rpv.2
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.34 99.39 0.39 19-615
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST 0.63
7rpv.3
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.36 99.39 0.39 19-615
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST 0.63
7p8i.1
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
 0.35 0.51 96.20 0.39 19-615
319-541		 X-ray 4.50 hetero-1-1-mer 2 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7p8i.2
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
 0.35 96.20 0.39 19-615
319-541		 X-ray 4.50 hetero-1-1-mer 3 x NAG, 2 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.61
7p8i.1
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
 0.36 97.32 0.39 19-615
319-541		 X-ray 4.50 hetero-1-1-mer 2 x NAG-NAG, 3 x NAG-NAG-BMA BLAST / HHblits 0.62
7p8i.2
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
 0.36 97.32 0.39 19-615
319-541		 X-ray 4.50 hetero-1-1-mer 3 x NAG, 2 x NAG-NAG, 1 x NAG-NAG-BMA BLAST / HHblits 0.62
7xbf.1
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
 0.35 0.54 96.23 0.40 18-615
316-541		 X-ray 3.51 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST 0.62
7xbf.2
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
 0.35 96.23 0.40 18-615
316-541		 X-ray 3.51 hetero-1-1-mer 5 x NAG, 1 x ZN BLAST 0.62
7drv.1
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
 0.35 0.59 96.19 0.39 19-614
319-541		 X-ray 3.09 hetero-1-1-mer 4 x NAG, 1 x ZN, 2 x NAG-NAG BLAST / HHblits 0.61
7drv.2
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
 0.35 96.19 0.39 19-614
319-541		 X-ray 3.09 hetero-1-1-mer 1 x ZN, 1 x NAG, 1 x NAG-NAG BLAST / HHblits 0.61
6vw1.1
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
 0.36 96.18 0.39 20-614
319-535		 X-ray 2.68 hetero-1-1-mer 1 x ZN, 1 x NAG, 3 x NAG-NAG-BMA, 2 x NAG-NAG BLAST / HHblits 0.62
6vw1.2
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
 0.35 0.59 96.18 0.39 20-614
319-535		 X-ray 2.68 hetero-1-1-mer 1 x ZN, 2 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-NAG BLAST / HHblits 0.62
7wbq.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
 0.35 98.77 0.39 20-613
319-541		 X-ray 3.34 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG, 1 x NAG-FUL HHblits 0.62
7wbq.2
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
 0.35 98.77 0.39 20-613
319-541		 X-ray 3.34 hetero-1-1-mer 6 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.62
7drv.1
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
 0.36 0.59 97.31 0.39 19-614
319-541		 X-ray 3.09 hetero-1-1-mer 4 x NAG, 1 x ZN, 2 x NAG-NAG BLAST 0.62
7drv.2
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
 0.36 97.31 0.39 19-614
319-541		 X-ray 3.09 hetero-1-1-mer 1 x ZN, 1 x NAG, 1 x NAG-NAG BLAST 0.62
7u0n.2
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2
 0.35 95.44 0.39 20-614
319-534		 X-ray 2.61 hetero-1-1-mer 3 x NAG, 1 x ZN, 1 x MG, 3 x NAG-NAG-BMA, 1 x NAG-NAG HHblits 0.61
7ufk.2
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2
 0.35 0.54 95.31 0.39 20-614
319-534		 X-ray 2.38 hetero-1-1-mer 1 x ZN, 3 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN HHblits 0.61
7rpv.1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.34 99.26 0.39 20-614
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN HHblits 0.63
7rpv.2
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.34 99.26 0.39 20-614
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN HHblits 0.63
7rpv.3
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.36 99.26 0.39 20-614
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN HHblits 0.63
7rpv.4
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.35 99.26 0.39 20-614
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN HHblits 0.63
7wbq.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
 0.36 99.76 0.39 20-613
319-541		 X-ray 3.34 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG, 1 x NAG-FUL BLAST / HHblits 0.63
7u0n.1
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2
 0.35 95.44 0.39 20-614
319-535		 X-ray 2.61 hetero-1-1-mer 5 x NAG, 1 x ZN, 2 x NAG-NAG-BMA BLAST / HHblits 0.61
7rpv.1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.35 99.38 0.39 20-614
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.63
7rpv.2
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.34 99.38 0.39 20-614
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.63
7rpv.3
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.36 99.38 0.39 20-614
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.63
7rpv.4
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
 0.35 99.38 0.39 20-614
320-537		 X-ray 3.54 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.63
7ufk.1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2
 0.36 95.32 0.39 20-614
319-535		 X-ray 2.38 hetero-1-1-mer 1 x ZN, 5 x NAG, 2 x NAG-NAG-BMA BLAST / HHblits 0.61
7wbp.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2
 0.36 97.67 0.39 20-613
319-541		 X-ray 3.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG HHblits 0.62
7wbp.1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2
 0.36 98.16 0.39 20-613
319-541		 X-ray 3.00 hetero-1-1-mer 5 x NAG, 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.62
7drv.1
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
 0.35 0.59 96.18 0.39 20-613
319-541		 X-ray 3.09 hetero-1-1-mer 4 x NAG, 1 x ZN, 2 x NAG-NAG HHblits 0.61
7drv.2
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
 0.35 96.18 0.39 20-613
319-541		 X-ray 3.09 hetero-1-1-mer 1 x ZN, 1 x NAG, 1 x NAG-NAG HHblits 0.61
7drv.1
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
 0.36 0.59 97.31 0.39 20-613
319-541		 X-ray 3.09 hetero-1-1-mer 4 x NAG, 1 x ZN, 2 x NAG-NAG BLAST / HHblits 0.62
7drv.2
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
 0.36 97.31 0.39 20-613
319-541		 X-ray 3.09 hetero-1-1-mer 1 x ZN, 1 x NAG, 1 x NAG-NAG BLAST / HHblits 0.62
7fdk.1
SARS-COV-2 Spike RBDMACSp36 binding to mACE2
 0.34 88.38 0.39 1-615
333-526		 EM 0.00 hetero-1-1-mer 3 x NAG BLAST / HHblits 0.59
7fdk.1
SARS-COV-2 Spike RBDMACSp36 binding to mACE2
 0.34 88.13 0.39 1-615
332-526		 EM 0.00 hetero-1-1-mer 3 x NAG HHblits 0.59
7xbf.1
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
 0.35 0.53 93.41 0.40 18-615
297-541		 X-ray 3.51 hetero-1-1-mer 6 x NAG, 1 x ZN BLAST / HHblits 0.60
7xbf.2
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
 0.35 93.41 0.40 18-615
297-541		 X-ray 3.51 hetero-1-1-mer 5 x NAG, 1 x ZN BLAST / HHblits 0.60
7ufl.1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2
 0.35 92.00 0.39 19-615
319-534		 X-ray 2.84 hetero-1-1-mer 1 x ZN, 3 x NAG, 1 x NAG-NAG-BMA BLAST / HHblits 0.60
7ufl.2
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2
 0.34 92.00 0.39 19-615
319-534		 X-ray 2.84 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA BLAST / HHblits 0.60
7fc5.1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
 0.35 90.52 0.38 19-615
335-528		 X-ray 2.89 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.60
7fc6.1
Crystal structure of SARS-CoV RBD and horse ACE2
 0.33 83.85 0.38 19-615
335-526		 X-ray 2.65 hetero-1-1-mer 2 x NAG, 1 x NAG-NAG BLAST / HHblits 0.57
7fc5.1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
 0.35 0.52 90.55 0.38 19-615
333-529		 X-ray 2.89 hetero-1-1-mer 5 x NAG BLAST 0.60
7fc5.1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
 0.35 90.48 0.38 20-613
335-528		 X-ray 2.89 hetero-1-1-mer 5 x NAG HHblits 0.60
7fc6.1
Crystal structure of SARS-CoV RBD and horse ACE2
 0.32 83.78 0.37 20-613
335-526		 X-ray 2.65 hetero-1-1-mer 2 x NAG, 1 x NAG-NAG HHblits 0.57
7fc5.1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
 0.35 0.52 90.52 0.38 20-613
333-529		 X-ray 2.89 hetero-1-1-mer 5 x NAG BLAST / HHblits 0.60
7f5r.2
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
 0.34 87.85 0.38 19-615
335-527		 X-ray 3.01 hetero-1-1-mer 3 x NAG BLAST / HHblits 0.59
7f5r.1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
 0.34 87.88 0.38 19-615
333-527		 X-ray 3.01 hetero-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-FUC BLAST 0.59
7f5r.2
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
 0.34 87.88 0.38 19-615
333-527		 X-ray 3.01 hetero-1-1-mer 3 x NAG BLAST 0.59
7f5r.2
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
 0.34 87.82 0.38 20-614
335-527		 X-ray 3.01 hetero-1-1-mer 3 x NAG HHblits 0.59
7f5r.3
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
 0.34 87.82 0.38 20-614
335-527		 X-ray 3.01 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG HHblits 0.59
7f5r.1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
 0.34 87.85 0.38 20-614
333-527		 X-ray 3.01 hetero-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-FUC BLAST / HHblits 0.59
7f5r.2
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
 0.34 87.85 0.38 20-614
333-527		 X-ray 3.01 hetero-1-1-mer 3 x NAG BLAST / HHblits 0.59
7f5r.3
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
 0.35 0.58 87.85 0.38 20-614
333-527		 X-ray 3.01 hetero-1-1-mer 1 x NAG, 1 x NAG-NAG BLAST / HHblits 0.59
7dhx.1
Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2
 0.35 89.07 0.39 18-614
319-527		 X-ray 2.30 hetero-1-1-mer 2 x NAG, 1 x ZN BLAST / HHblits 0.59
7dhx.1
Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2
 0.36 0.49 89.21 0.39 18-614
319-527		 X-ray 2.30 hetero-1-1-mer 2 x NAG, 1 x ZN BLAST 0.59
7w6u.1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2
 0.35 0.55 90.70 0.39 20-614
319-541		 X-ray 2.56 hetero-1-1-mer 1 x ZN, 1 x NAG HHblits 0.60
7w6u.1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2
 0.36 90.83 0.39 20-614
319-541		 X-ray 2.56 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.60
7w6r.1
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
 0.34 0.53 86.98 0.39 19-614
319-541		 X-ray 2.60 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.58
7w6r.1
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
 0.35 0.53 88.16 0.39 19-614
319-541		 X-ray 2.60 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST 0.59
7wsk.1
Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2
 0.33 86.97 0.40 18-617
319-541		 X-ray 3.30 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG-MAN BLAST / HHblits 0.58
7wsk.1
Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2
 0.34 0.56 87.48 0.40 18-617
319-541		 X-ray 3.30 hetero-1-1-mer 4 x NAG, 1 x ZN, 1 x NAG-NAG-MAN BLAST 0.59
7w6r.1
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
 0.34 0.53 86.96 0.39 20-614
319-541		 X-ray 2.60 hetero-1-1-mer 1 x ZN, 1 x NAG HHblits 0.58
7w6r.1
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
 0.35 0.53 88.14 0.39 20-614
319-541		 X-ray 2.60 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.59
7w8s.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
 0.32 0.52 88.28 0.39 19-615
319-541		 EM 0.00 hetero-1-1-mer 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.59
7w8s.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
 0.32 88.41 0.39 19-615
319-541		 EM 0.00 hetero-1-1-mer 1 x ZN, 1 x NAG-NAG BLAST 0.59
7w8s.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
 0.32 0.52 88.16 0.39 20-616
319-541		 EM 0.00 hetero-1-1-mer 1 x ZN, 1 x NAG-NAG HHblits 0.59
7wa1.1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with American mink ACE2
 0.36 88.16 0.39 20-616
319-541		 EM 0.00 hetero-1-1-mer 1 x ZN HHblits 0.59
7w8s.1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
 0.32 88.29 0.39 20-616
319-541		 EM 0.00 hetero-1-1-mer 1 x ZN, 1 x NAG-NAG BLAST / HHblits 0.59
7xa7.1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
 0.35 84.88 0.39 18-615
319-541		 X-ray 3.31 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.58
7xa7.2
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
 0.35 84.88 0.39 18-615
319-541		 X-ray 3.31 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.58
7xa7.4
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
 0.35 84.88 0.39 18-615
319-541		 X-ray 3.31 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.58
7xa7.1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
 0.35 85.02 0.40 18-615
319-541		 X-ray 3.31 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST 0.58
7xa7.2
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
 0.35 85.02 0.40 18-615
319-541		 X-ray 3.31 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST 0.58
7xa7.3
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
 0.35 84.84 0.39 19-614
319-541		 X-ray 3.31 hetero-1-1-mer 1 x ZN, 1 x NAG HHblits 0.58
7xa7.3
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
 0.35 84.98 0.39 19-614
319-541		 X-ray 3.31 hetero-1-1-mer 1 x ZN, 1 x NAG BLAST / HHblits 0.58
7wpz.1
Structure of PDF-2180-COV RBD binding to Bat37 ACE2
 0.32 64.32 0.38 20-616
330-526		 EM 0.00 hetero-1-1-mer 4 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN BLAST / HHblits 0.50
7wpz.1
Structure of PDF-2180-COV RBD binding to Bat37 ACE2
 0.32 63.97 0.38 21-615
330-526		 EM 0.00 hetero-1-1-mer 4 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN HHblits 0.49